Insuficiencia cardíaca crónica en Argentina. OFFICE IC AR, un registro conjunto de la Sociedad Argentina de Cardiología y de la Federación Argentina de …
J Thierer, ER Perna, J Marino… - Revista argentina de …, 2022 - SciELO Argentina
Objetivos: Describir en forma amplia y comprensiva las características salientes de la ICC
en Argentina, incluyendo las características de los pacientes, el uso de recursos …
en Argentina, incluyendo las características de los pacientes, el uso de recursos …
The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction
K Iwakura, T Onishi, A Okamura, Y Koyama… - Scientific Reports, 2024 - nature.com
The coexistence of heart failure is frequent and associated with higher mortality in patients
with type 2 diabetes (T2DM), and its management is a critical issue. The WATCH-DM risk …
with type 2 diabetes (T2DM), and its management is a critical issue. The WATCH-DM risk …
Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction
Y Wongsalap, D Poolpun, K Keawhai… - Chronic Diseases and …, 2023 - mednexus.org
Background: This study aimed to assess the prescribing patterns of evidence-based
pharmacotherapy and their association with clinical outcomes in patients with heart failure …
pharmacotherapy and their association with clinical outcomes in patients with heart failure …
Regional variations in heart failure: a global perspective
V Yogeswaran, D Hidano, AE Diaz, HGC Van Spall… - Heart, 2024 - heart.bmj.com
Heart failure (HF) is a global public health concern that affects millions of people worldwide.
While there have been significant therapeutic advancements in HF over the last few …
While there have been significant therapeutic advancements in HF over the last few …
[HTML][HTML] Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway
M Zuo, T Tang, X Wang, J Gu, L Wang… - Evidence-Based …, 2022 - hindawi.com
The objective of this study was to determine the effect of atractylenolide III (ATL-III) on
endoplasmic reticulum stress (ERS) injury, H9c2 cardiomyocyte apoptosis induced by …
endoplasmic reticulum stress (ERS) injury, H9c2 cardiomyocyte apoptosis induced by …
Cost-effectiveness analysis of sacubitril/valsartan compared to enalapril for heart failure patients in Indonesia
Objective Sacubitril/valsartan is a relatively new medication that is more effective than the
usual enalapril for heart failure patients with reduced ejection fraction. Therefore, this study …
usual enalapril for heart failure patients with reduced ejection fraction. Therefore, this study …
Regional disparities and risk factors of mortality among patients at high risk of sudden cardiac death in emerging countries: a nonrandomized controlled trial
S Zhao, CK Ching, D Huang, YB Liu… - BMC medicine, 2024 - Springer
Background Comprehensive data on patients at high risk of sudden cardiac death (SCD) in
emerging countries are lacking. The aim was to deepen our understanding of the SCD …
emerging countries are lacking. The aim was to deepen our understanding of the SCD …
[HTML][HTML] Clinical phenotypes and age-related differences in presentation, treatment, and outcome of heart failure with preserved ejection fraction: a Vietnamese …
NTV Nguyen, DT Tran, P Le An, S Van Hoang… - … Research and Practice, 2021 - hindawi.com
Background. Heart failure with preserved ejection fraction (HFpEF) is a rising health problem
with heterogeneous presentation and no evidence-based treatment. While Southeast Asia …
with heterogeneous presentation and no evidence-based treatment. While Southeast Asia …
Financial burden of heart failure in Malaysia: A perspective from the public healthcare system
SC Ong, JZ Low - Plos one, 2023 - journals.plos.org
Background Estimating and evaluating the economic burden of HF and its impact on the
public healthcare system is necessary for devising improved treatment plans in the future …
public healthcare system is necessary for devising improved treatment plans in the future …
[HTML][HTML] Inter-ethnic differences in cardiovascular disease: impact on therapies and outcomes
The prevalence of cardiovascular disease varies among countries and reflect multifactorial
differences such as genetic predisposition, diet, and social activity. The Asian population …
differences such as genetic predisposition, diet, and social activity. The Asian population …